Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values

Table 3

Annual evolution of BP (mm Hg/year) during the follow-up.

	NT (n = 434)	WCHT untreated (n = 399)	WCHT treated (n = 156)	ANOVA  <
SBPc (mm Hg)	1.2 ± 0.95	−1.36 ± 1.35	−2.03 ± 1.56	0.01
DBPc (mm Hg)	1.01 ± 0.77	−0.98 ± 0.97	−1.13 ± 0.75	0.01
SBP 24 h (mm Hg)	0.53 ± 0.93	0.76 ± 1.06	0.35 ± 1.01	0.01
DBP 24 h (mm Hg)	0.22 ± 0.95	0.39 ± 1.11	0.12 ± 0.71	0.01
SBP daytime (mm Hg)	0.54 ± 1.00	0.58 ± 1.48	0.37 ± 1.34	0.01
DBP daytime (mm Hg)	0.28 ± 1.05	0.38 ± 1.94	0.11 ± 0.92	0.01
SBP nighttime (mm Hg)	0.54 ± 0.84	0.63 ± 1.03	0.33 ± 0.92	0.01
DBP nighttime (mm Hg)	0.21 ± 0.89	0.33 ± 1.00	0.11 ± 0.87	0.01

NT, normotensives; WCHT, white-coat hypertensives; SBPc, office systolic BP; DBPc, office diastolic BP; HRc, office heart rate; Delta, difference between baseline and the end of the follow-up (final). Post hoc analysis: vs. NT different from WCHT treated.